Therapeutic value is the primary driver of self-management decisions in heart failure patients, with decision influences varying by NYHA class.
No takes yet. Share an insight, caveat, or question.
Therapeutic value may guide HF self-management support; cross-sectional data leaves open causal effects and needs prospective validation.
Hicks et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: